Back to search results

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Abroad (travel likely)RecruitingPHASE2

Conditions

Antibody-Mediated Rejection · Kidney Transplantation · Biopsy-proven Histologic Scores · AMR

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Birmingham, Alabama, United States

  • Research Site, Scottsdale, Arizona, United States

  • Research Site, Los Angeles, California, United States

  • Research Site, Orange, California, United States

  • Research Site, Tampa, Florida, United States

  • Research Site, Atlanta, Georgia, United States

  • Research Site, Kansas City, Kansas, United States

  • Research Site, Ann Arbor, Michigan, United States

  • Research Site, Detroit, Michigan, United States

  • Research Site, Livingston, New Jersey, United States

  • Research Site, New York, New York, United States

  • Research Site, New York, New York, United States

  • Research Site, New York, New York, United States

  • Research Site, New York, New York, United States

  • Research Site, Durham, North Carolina, United States

  • Research Site, Cincinnati, Ohio, United States

  • Research Site, Philadelphia, Pennsylvania, United States

  • Research Site, Charleston, South Carolina, United States

  • Research Site, Dallas, Texas, United States

  • Research Site, Houston, Texas, United States

  • Research Site, Richmond, Virginia, United States

  • Research Site, Seattle, Washington, United States

  • Research Site, Milwaukee, Wisconsin, United States

  • Research Site, Botucatu, Brazil

  • Research Site, Campinas, Brazil

  • Research Site, Porto Alegre, Brazil

  • Research Site, São Paulo, Brazil

  • Research Site, São Paulo, Brazil

  • Research Site, Calgary, Alberta, Canada

  • Research Site, Edmonton, Alberta, Canada

  • Research Site, Vancouver, British Columbia, Canada

  • Research Site, London, Ontario, Canada

  • Research Site, Toronto, Ontario, Canada

  • Research Site, Montreal, Quebec, Canada

  • Research Site, Changsha, China

  • Research Site, Guangzhou, China

  • Research Site, Nanning, China

  • Research Site, Shanghai, China

  • Research Site, Wuhan, China

  • Research Site, Xi'an, China

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Barcelona, Spain

  • Research Site, Barcelona, Spain

  • Research Site, Zaragoza, Spain

  • Research Site, Kaohsiung City, Taiwan

  • Research Site, Kaohsiung City, Taiwan

  • Research Site, Taichung, Taiwan

  • Research Site, Taoyuan, Taiwan

  • Research Site, Birmingham, United Kingdom

  • Research Site, London, United Kingdom

  • Research Site, London, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)